June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
The Macula Progression Study (MAPS): Repeatability of a Single, Wide-field, Swept-Source Optical Coherence Tomography Protocol
Author Affiliations & Notes
  • C Gustavo De Moraes
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Jeffrey M Liebmann
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Jeremy Reimann
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Lam Lu
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Lama Al-Aswad
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Dana Blumberg
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • George A Cioffi
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Robert Ritch
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Donald Hood
    Ophthalmology, Columbia University Medical Center, New York, New York, United States
  • Footnotes
    Commercial Relationships   C Gustavo De Moraes, None; Jeffrey Liebmann, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (C), Dyopsis Inc. (C), Pfizer Inc. (C), Topcon Medical Systems Inc. (C); Jeremy Reimann, None; Lam Lu, None; Lama Al-Aswad, None; Dana Blumberg, None; George Cioffi, None; Robert Ritch, Diopsys Inc. (I), Dyopsis Inc. (C), iSonic Medical (C), Ocular Instruments (P), Pfizer Inc. (C), Sensimed, AG (C), Topcon Medical Systems Inc (I), Topcon Medical Systems Inc (C); Donald Hood, Topcon, Inc. (C)
  • Footnotes
    Support  NIH/NEI Grant EY025253
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 4258. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      C Gustavo De Moraes, Jeffrey M Liebmann, Jeremy Reimann, Lam Lu, Lama Al-Aswad, Dana Blumberg, George A Cioffi, Robert Ritch, Donald Hood; The Macula Progression Study (MAPS): Repeatability of a Single, Wide-field, Swept-Source Optical Coherence Tomography Protocol. Invest. Ophthalmol. Vis. Sci. 2017;58(8):4258.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Commercially-available software for detecting progression with OCT do not employ a reference database with patient data repeated over short intervals to help differentiate progression from variability. We have described and validated a single wide-field swept-source optical coherence tomography (ssOCT) protocol to diagnose early glaucoma.[1] To test the feasibility of using this single scan protocol to detect the progression of glaucoma, we assessed the repeatability of its measures.

Methods : In this prospective cohort study, we included 124 eyes (124 subjects (52 healthy controls; 16 glaucoma suspects; and 56 early manifest glaucoma) with 24-2 mean deviation (MD) > -6 dB). All participants had ssOCT wide-field scans (9x12 mm, DRI-OCT, Topcon, Inc., Tokyo, Japan) and 24-2 and 10-2 visual field tests on the same day, which were repeated at least four times within an 8 week period. For quantitative analysis, we calculated the 90% limits of variability of local and global macular retinal ganglion cell plus inner plexiform layer (RGC+) and circumpapillary retinal nerve fiber layer (cpRNFL) thicknesses. Changes exceeding the upper 5% and 1% limits are deemed “possible” and “likely” progression, respectively. For qualitative analysis, two expert graders reviewed all sequential images to assess the repeatability of the single wide-field ssOCT report.

Results : The repeatability of RGC+ and cpRNFL thickness measurements was excellent (ICC= 0.96 and 0.98, respectively). The expert grader did not flag any significant changes in participants’ reports over time using the repeatability data. Figure 1 depicts an example of a patient with double arcuate scotomata affecting the macula. The wide-field reports of tests performed 4 weeks apart were very similar.

Conclusions : Given its excellent repeatability, a single wide-field ssOCT report may be useful not only to diagnose early glaucoma,[1] but also to detect early signs of structural progression.

REFERENCE
1. Hood et al., TVST 2016:5(6):4

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×